Trials / Completed
CompletedNCT02887495
The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (estimated)
- Sponsor
- George Washington University · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The Scleroderma bioreposiTOry and Pathogenesis Study (STOP Scleroderma) will help researchers use clinical data and human biospecimens to investigate why scleroderma patients develop certain complications from their disease. Patients with confirmed scleroderma, raynauds or positive autoantibodies are invited to participate. This research may help us understand how to prevent and treat scleroderma and other diseases.
Conditions
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2022-02-02
- Completion
- 2022-02-02
- First posted
- 2016-09-02
- Last updated
- 2022-07-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02887495. Inclusion in this directory is not an endorsement.